Gilead Sciences Inc (GILD)
107.27
+0.53
(+0.50%)
USD |
NASDAQ |
Mar 25, 10:05
Gilead Sciences Total Assets (Quarterly): 59.00B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 91.84B |
| Johnson & Johnson | 180.10B |
| Eli Lilly and Co | 78.71B |
| Vertex Pharmaceuticals Inc | 22.53B |
| Moderna Inc | 14.14B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.75B |
| Shareholders Equity (Quarterly) | 19.33B |
| Debt to Equity Ratio | 1.382 |
| Current Ratio | 1.597 |
| Net Debt Paydown Yield | -0.30% |